Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype

Acta Myologica

Volumn 30, Issue DECEMBER, 2011, Pages 182-184

  Witting, Nanna ^a   Duno, Morten ^a   Vissing, John ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

BMD; Deletion; Dystrophin; Exon 26

Indexed keywords

ALPHA SARCOGLYCAN; BETA DYSTROGLYCAN; BOTULINUM TOXIN; CALPAIN; CLONAZEPAM; CREATINE KINASE; DYSTROPHIN; MEROSIN; ORPHENADRINE;

ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CASE REPORT; CELL NUCLEUS; CLINICAL EXAMINATION; COMORBIDITY; DYSTONIA; EXON; GENE DELETION; HUMAN; HUMAN TISSUE; MALE; MENTAL DEFICIENCY; MOTOR ACTIVITY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE WEAKNESS; MYALGIA;

ADULT; DYSTROPHIN; EXONS; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; PHENOTYPE; SEQUENCE DELETION; YOUNG ADULT;

EID: 84857721441     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Backman E, Henriksson KG. Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy. Neuromuscul Disord 1995;5:233-41.
2. Goemans NM, Tulinius M, van den Akker JT, et al. Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med 2011;364:1513-22.
3. Lu QL, Yokota T, Takeda S, et al. The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy. Mol Ther 2011;19:9-15.
4. Anderson LV, Davison K. Multiplex Western blotting system for the analysis of muscular dystrophy proteins. Am J Pathol 1999;154:1017-22. (Pubitemid 29169736)
5. Artsma-Rus A, van Deutekom JC, Fokkema IF, et al. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 2006;34:135-44. (Pubitemid 44167796)
6. Garwal-Mawal A, Vanasse M, Simard LR. Novel 3678delA mutation in exon 26 of the dystrophin gene causing Duchenne muscular dystrophy. Hum Mutat 1998;Suppl 1:S23-S24.
7. Wilton SD, Chandler DC, Kakulas BA, et al. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family. Hum Mutat 1994;3:133-40. (Pubitemid 24077230)
8. Bulman DE, Gangopadhyay SB, Bebchuck KG, et al. Point mutation in the human dystrophin gene: identification through western blot analysis. Genomics 1991;10:457-60.
9. Schwartz M, Duno M, Palle AL, et al. Deletion of exon 16 of the dystrophin gene is not associated with disease. Hum Mutat 2007;28:205.
10. Saengpattrachai M, Ray PN, Hawkins CE, et al. Grandpa and I have dystrophinopathy?: approach to asymptomatic hyperCKemia. Pediatr Neurol 2006;35:145-9. (Pubitemid 44093977)